DCE PLATFORM Trademark

Trademark Overview

On Thursday, January 7, 2010, a trademark application was filed for DCE PLATFORM with the United States Patent and Trademark Office. The USPTO has given the DCE PLATFORM trademark a serial number of 77907107. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 24, 2023. This trademark is owned by Concert Pharmaceuticals, Inc.. The DCE PLATFORM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

scientific and medical research services; medical testing services for research purposes; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; pharmaceutical research services
dce platform

General Information

Serial Number77907107
Word MarkDCE PLATFORM
Filing DateThursday, January 7, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 24, 2023
Registration Number4206340
Registration DateTuesday, September 11, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2011

Trademark Statements

Disclaimer with Predetermined Text"PLATFORM"
Goods and Servicesscientific and medical research services; medical testing services for research purposes; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; pharmaceutical research services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 24, 2023
Primary Code042
First Use Anywhere DateSunday, April 1, 2012
First Use In Commerce DateSunday, April 1, 2012

Trademark Owner History

Party NameConcert Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameConcert Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameConcert Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Friday, March 24, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, September 11, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, September 20, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, September 20, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, September 20, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 11, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, September 11, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 12, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 11, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, August 7, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 6, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, August 6, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 12, 2012STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 17, 2012USE AMENDMENT FILED
Tuesday, June 12, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 17, 2012TEAS STATEMENT OF USE RECEIVED
Thursday, May 17, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 18, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 16, 2011SOU EXTENSION 1 GRANTED
Wednesday, November 16, 2011SOU EXTENSION 1 FILED
Wednesday, November 16, 2011TEAS EXTENSION RECEIVED
Tuesday, May 17, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 22, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2011PUBLISHED FOR OPPOSITION
Wednesday, February 16, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 15, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 25, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 25, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 25, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 27, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 27, 2010NON-FINAL ACTION E-MAILED
Tuesday, July 27, 2010NON-FINAL ACTION WRITTEN
Friday, July 9, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 9, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 6, 2010ASSIGNED TO LIE
Wednesday, June 16, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 30, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 30, 2010NON-FINAL ACTION E-MAILED
Tuesday, March 30, 2010NON-FINAL ACTION WRITTEN
Tuesday, March 30, 2010ASSIGNED TO EXAMINER
Wednesday, January 13, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 11, 2010NEW APPLICATION ENTERED

Related Keywords

platform services research medical pharmaceuticals drug pharmaceutical field discovery conducting testing